Patent details

EP2650012 Title: Treatment of metastatic stage prostate cancer with degarelix

Basic Information

Publication number:
EP2650012
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP131684045
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Treatment of metastatic stage prostate cancer with degarelix
French Title of Invention:
Traitement du cancer de la prostate au stade métastasique par le degarelix
German Title of Invention:
Behandlung von Prostatakrebs im Metastasenstadium mit Degarelix
SPC Number:

Dates

Filing date:
10/02/2009
Grant date:
25/03/2015
EP Publication Date:
25/03/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/10/2013
EP B1 Publication Date:
25/03/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
10/02/2029
Renunciation date:
Revocation date:
08/02/2022
Annulment date:

Owner

From:
10/02/2009
 
 

Name:
Ferring B.V.
Address:
Polaris Avenue 144, 2132 JX Hoofddorp, Netherlands (NL)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
15/04/2015
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
Persson Bo-Eric
Address:
Switzerland (CH)

Priority

1

Priority Number:
27741 P
Priority Date:
11/02/2008
Priority Country:
United States (US)

2

Priority Number:
08250703
Priority Date:
29/02/2008
Priority Country:
European Patent Office (EPO) (EP)

3

Priority Number:
147956 P
Priority Date:
28/01/2009
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/09;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2022/05
Publication date:
01/04/2022
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

Issue number:
202212
Publication date:
23/03/2022
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
24/02/2022
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
IPAN GMBH
Filing date Document type Number of pages